Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
203.00    0.40 (0.20%)
Bid:
202.40
Ask:
203.40
Spread: 1.00 (0.494%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Jul 2009 07:00

RNS Number : 7555V
Ashmore Group PLC
16 July 2009
Β 

ο»Ώ

Β Ashmore Group plc

+0700 16Β JulyΒ 2009Β 

TRADINGΒ UPDATEΒ AND ASSETS UNDER MANAGEMENTΒ sTATEMENT

Ashmore Group plc ("Ashmore", the "Group"), a leading specialist emerging markets asset manager,Β announces the followingΒ tradingΒ updateΒ and Assets under Management ("AuM")Β statementΒ inΒ respect of the period ended 30Β JuneΒ 2009.

Assets underΒ Management

ActualΒ 

EstimatedΒ 

Estimated

Theme

31 March

2009

(US$ billion)

30 June

2009

(US$ billion)

Movement

Q3vsQ4

(%)

External DebtΒ 

14.4

16.0

+11%

Local Currency

4.6

4.5

-2%

Special Situations

4.4

4.3

-2%

Equity

0.1

0.1

-

Total

23.5

24.9

+6%

TheΒ final quarter of the financial year ended 30 JuneΒ 2009Β sawΒ AuMΒ increase byΒ US$1.4Β billion (6%)Β to US$24.9Β billion. This increase comprisesΒ investment performance of US$1.9Β billion, arising in external debt and local currency, partially offset byΒ netΒ redemptions of US$0.5Β billion,Β solely withinΒ theΒ localΒ 

currencyΒ theme.

During theΒ financial year ended 30 JuneΒ 2009,Β AuMΒ decreasedΒ to US$24.9Β billionΒ fromΒ US$37.5Β billion. Investment performanceΒ wasΒ US$5.1 billionΒ adverse;Β US$7.1 billionΒ adverseΒ in the first half, and US$2.0 billion positive in the second half. NetΒ redemptionsΒ in the period were US$7.4Β billion, of whichΒ US$5.7 billionΒ aroseΒ in the first half of the yearΒ across all themes, largely reflecting the liquidity needs of our clients in the extreme market conditions. Over the second half, redemptions have slowed significantly, while subscription levelsΒ have begun toΒ increaseΒ within both public funds and segregated mandates, with net subscriptionsΒ achieved in May and June. Β 

TheΒ expansion of theΒ average revenue margin experienced in the first half, principally because of the AuM mix,Β has beenΒ impactedΒ byΒ theΒ timing and make up ofΒ external debt andΒ local currency redemptions at the back end of the first half, and through the second half. This hasΒ resulted in theΒ averageΒ revenue marginΒ for the final quarter returning to the FY07/08 level of 103bps.Β Β 

The results for the full yearΒ ended 30 June 2009Β are in-line with management expectationsΒ in the current operating environment. The loss for the year in respect of FX hedge contractsΒ is Β£42.8Β millionΒ (6 months toΒ 31 December 2008: Β£54.2 million),Β of whichΒ Β£4.5Β millionΒ (6 months toΒ 31 December 2008: Β£12.7 million)Β relates toΒ the mark-to-market of forwardΒ contractsΒ toΒ partially hedge FY09/10 management fees. TheseΒ FY09/10Β forward contractsΒ haveΒ an aggregateΒ notionalΒ valueΒ 

ofΒ US$120 million,Β marked at the year end rate of GBP1:1.6458USD. Any futureΒ gainsΒ or lossesΒ on these contracts will arise from deviations fromΒ thisΒ year end rate.

The Group will announce its results in respect of the financial year to 30 JuneΒ 2009Β onΒ 

15Β SeptemberΒ 2009.Β There will be a presentation for analysts at 0900 on that date at the offices of Goldman Sachs atΒ Peterborough Court,Β 133 Fleet StreetΒ LondonΒ EC4A 2BB. A copy of the presentation will be made available on the Group's website at www.ashmoregroup.com.

For further information,Β please contact:

AshmoreΒ Group plc

Graeme Dell, Group FinanceΒ Director +44 (0)20 3077 6000

PenroseΒ FinancialΒ  +44(0)20 7786 4888Β 

GayΒ Collins +44(0)7798Β 626282

Ashmore@penrose.co.ukΒ 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTIFFVLDEIELIA
Date   Source Headline
19th Aug 20242:55 pmRNSHolding(s) in Company
12th Jul 20247:00 amRNSTrading statement
31st May 20244:17 pmRNSHolding(s) in Company
31st May 20243:15 pmRNSDirector/PDMR Shareholding
1st May 20243:01 pmRNSDirectorate Change
1st May 202411:11 amRNSDirector/PDMR Shareholding
18th Apr 20241:11 pmRNSDirectorate Change
15th Apr 20247:00 amRNSTrading Statement
18th Mar 20243:30 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:30 amRNSHolding(s) in Company
11th Dec 202311:21 amRNSDirector/PDMR Shareholding
18th Oct 20232:13 pmRNSResult of AGM
13th Oct 20237:00 amRNSTrading Statement
19th Sep 202311:00 amRNSDirector/PDMR Shareholding
19th Sep 202310:08 amRNSHolding(s) in Company
15th Sep 20235:06 pmRNSHolding(s) in Company
14th Sep 20232:56 pmRNSNotice of AGM
14th Sep 202310:29 amRNSDirector/PDMR Shareholding
6th Sep 20237:00 amRNSFinal Results
14th Jul 20231:51 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSTrading Statement
11th Jul 20232:10 pmRNSHolding(s) in Company
10th Jul 20232:48 pmRNSHolding(s) in Company
30th Jun 20235:11 pmRNSHolding(s) in Company
29th Jun 20239:09 amRNSHolding(s) in Company
14th Jun 20239:23 amRNSHolding(s) in Company
19th May 20238:35 amRNSDirector Declaration
21st Apr 20237:00 amRNSDirectorate Change
17th Apr 20237:00 amRNSTrading Statement
14th Apr 20239:30 amRNSAGM Statement
31st Mar 20232:33 pmRNSDirector/PDMR Shareholding
17th Mar 202310:21 amRNSDirector/PDMR Shareholding
13th Mar 202310:23 amRNSAudit tender process
8th Mar 20239:48 amRNSHolding(s) in Company
27th Feb 20239:41 amRNSHolding(s) in Company
16th Feb 20234:53 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSHalf-year Report
3rd Feb 20233:02 pmRNSHolding(s) in Company
25th Jan 20233:25 pmRNSHolding(s) in Company
24th Jan 20236:12 pmRNSHolding(s) in Company
23rd Jan 20239:01 amRNSHolding(s) in Company
19th Jan 20234:55 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSTrading Statement
12th Jan 20233:26 pmRNSHolding(s) in Company
11th Jan 20234:27 pmRNSHolding(s) in Company
9th Jan 20233:13 pmRNSHolding(s) in Company
5th Jan 20235:14 pmRNSHolding(s) in Company
16th Dec 20223:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.